Curated factual news snippets — click through to read full articles
[Home] [Topics]
[TZ: Australia/Sydney]
    [Raise a Problem] [About] [Admin]

    Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal

    --------------------------------------------------------------------
    Source: South China Morning Post
    Published: 2026-02-06 20:00 UTC+10:00
    Section: General
    Factuality Score: 100
    Opinion Category: Neutral
    Topics: Health, Asia, China, Drugs, World News, Business & Economy, Asia Pacific
    --------------------------------------------------------------------
    Snippet:
    The deal comes as Chinese novel drug makers are having more say in how their new medicines are developed with global partners
    --------------------------------------------------------------------
    >>> Read full article at South China Morning Post <<<
    <-- Back to Home

    This site displays brief snippets of news articles and links to the original publishers. Click the source link to read the full article on their site.

    Powered by Nebulex Pty Ltd Australia

    < >
    [Close]